RobertG.TrappMD

PubMed

• 75 citations
  Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene:...
  Philip J. Mease, Nathan Wei, Edward J. Fudman, Alan Kivitz, Joy Schechtman, Robert G. Trapp, Kathryn Hobbs, Maria Greenwald, Antony Hou, Stephen A. Bookbinder, Galen E...> ;The Journal of Rheumatology. 2010 Apr 1
• 153 citations
  Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, d...
  Mark C. Genovese, Jeffrey L. Kaine, Mitchell B. Lowenstein, Jose Del Giudice, Andrew R. Baldassare, Joy Schechtman, Edward J. Fudman, Michael Kohen, Sheila Gujrathi, R...> ;Arthritis and Rheumatism. 2008 Sep 1
• B-type natriuretic peptide and severe heart failure at baseline predict overall mortality in incident dialysis patients.
  Koch, M., Trapp, R., Kohnle, M., Aker, S., Haastert, B., Rump, L. C.> ;Clin Nephrol. 2010 Jan
• Nailfold capillaroscopy in type I diabetics with vasculopathy and limited joint mobility.
  Trapp, R. G., Soler, N. G., Spencer-Green, G.> ;J Rheumatol. 1986 Oct 01
• C4 binding protein deficiency in a patient with atypical Behçet's disease.
  Trapp, R. G., Fletcher, M., Forristal, J., West, C. D.> ;J Rheumatol. 1987 Feb
• Hereditary complement (C6) deficiency associated with systemic lupus erythematosus, Sjögren's syndrome and hyperthyroidism.
  Trapp, R. G., Mooney, E., Coleman, T. H., Forristal, J., Herman, J. H.> ;J Rheumatol. 1987 Oct
• Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.
  Deodhar, A., Dore, R. K., Mandel, D., Schechtman, J., Shergy, W., Trapp, R., Ory, P. A., Peterfy, C. G., Fuerst, T., Wang, H., Zhou, L., Tsuji, W., Newmark, R.> ;Arthritis Care Res (Hoboken). 2010 Apr
• Join now to see all